Chris Hall was appointed as a Non-Executive Director in September 2025. As Mr Hall was nominated for appointment by Tanarra Capital, he is not considered independent.
Chris brings to the Board extensive experience across asset management, superannuation and, recently, biotechnology. His career has included roles as Chair, Non-Executive Director and Chief Investment Officer, along with senior executive positions in Australia and Hong Kong.
Chris’ current roles include Chair of BiomeBank, Non-Executive Director, Investment Committee Chair and Audit Committee Member of AMP Super, Non-Executive Director and Chair of the Audit & Risk Committee of Funds SA, Investment Committee Chair of Perks Private Wealth, Member of the Advisory Board to the Long-Term Value Fund at Tanarra Capital, and a Member of the Merlon Capital Partners Advisory Board.
Chris holds a Bachelor of Business from the University of South Australia and has completed the Professional Management Program (MBA Program) at the University of Adelaide. He is also a member of the Australian Institute of Company Directors.